StockDrifts LogoStockDrifts

Odyssean LLC 13F Portfolio

Portfolio Manager
Odyssean LLC
Performance
+5.34% (2026 Q2)
AUM (13F)
$614.88M
# of Holdings
485
Performance Rank
N/A
Allocation (Top 20)
11.34%
Latest filing
Q2 2026

Odyssean LLC Holdings Map

Top 50 Odyssean LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
RARE
ULTRAGENYX PHARMACEUTICAL IN
0.66%122.1K$4.1M
+81.11%(+54.67K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 22.2K shares2026-Q1: 67.4K shares2026-Q2: 122.1K shares
$24.76(+6.97%)
2026-06-30
KYMR
KYMERA THERAPEUTICS INC
0.64%34.5K$4.0M
+132.68%(+19.66K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 9.3K shares2026-Q1: 14.8K shares2026-Q2: 34.5K shares
$86.36(+35.94%)
2026-06-30
IDYA
IDEAYA BIOSCIENCES INC
0.62%102.6K$3.8M
+571.61%(+87.31K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 21.1K shares2026-Q1: 15.3K shares2026-Q2: 102.6K shares
$33.84(+7.26%)
2026-06-30
PCVX
VAXCYTE INC
0.59%62.6K$3.6M
+211.46%(+42.53K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 16.2K shares2026-Q1: 20.1K shares2026-Q2: 62.6K shares
$52.27(+11.09%)
2026-06-30
AFRM
AFFIRM HLDGS INC
0.58%44.0K$3.6M
+139.10%(+25.58K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 10.0K shares2026-Q1: 18.4K shares2026-Q2: 44.0K shares
$64.49(+21.49%)
2026-06-30
CLDX
CELLDEX THERAPEUTICS INC NEW
0.58%95.1K$3.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 95.1K shares
$33.34(+25.81%)
2026-06-30
LOAR
LOAR HOLDINGS INC
0.57%43.7K$3.5M
+111.29%(+23.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 11.0K shares2026-Q1: 20.7K shares2026-Q2: 43.7K shares
$68.29(+13.36%)
2026-06-30
MIRM
MIRUM PHARMACEUTICALS INC
0.57%29.9K$3.5M
+149.95%(+17.95K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 9.3K shares2026-Q1: 12.0K shares2026-Q2: 29.9K shares
$92.81(+8.44%)
2026-06-30
DASH
DOORDASH INC
0.57%18.9K$3.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 3.2K shares2026-Q1: 0 shares2026-Q2: 18.9K shares
$180.52(+20.22%)
2026-06-30
KRYS
KRYSTAL BIOTECH INC
0.57%9.3K$3.5M
+94.00%(+4.53K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 3.0K shares2026-Q1: 4.8K shares2026-Q2: 9.3K shares
$266.80(+24.54%)
2026-06-30

About Odyssean LLCโ€™s portfolio

Odyssean LLC reports $614.88M in US-listed equity holdings across 485 positions in its most recent 13F filing. Its largest disclosed positions are RARE (0.7%), KYMR (0.6%) and IDYA (0.6%). The top 20 holdings account for 11.34% of reported assets. Its disclosed equity book has returned +2.95% cumulatively over 2 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
RARE โ€” 2.5% ($4.08M)KYMR โ€” 2.4% ($3.95M)IDYA โ€” 2.3% ($3.82M)PCVX โ€” 2.2% ($3.64M)AFRM โ€” 2.2% ($3.59M)CLDX โ€” 2.2% ($3.54M)LOAR โ€” 2.1% ($3.52M)MIRM โ€” 2.1% ($3.50M)DASH โ€” 2.1% ($3.49M)KRYS โ€” 2.1% ($3.47M)Other โ€” 77.7% ($127.60M)
22%in top 10
  • RARE2.5%
  • KYMR2.4%
  • IDYA2.3%
  • PCVX2.2%
  • AFRM2.2%
  • CLDX2.2%
  • LOAR2.1%
  • MIRM2.1%
  • DASH2.1%
  • KRYS2.1%
  • Other77.7%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
10
CLDXCELLDEX THERAPEUTICS INC NEW0.6%
DASHDOORDASH INC0.6%
MEDPMEDPACE HLDGS INC0.6%
NUNU HLDGS LTD0.5%
+6 opened
Added to
39
IDYAIDEAYA BIOSCIENCES INC+571.6%
RDNTRADNET INC+377.9%
PCVXVAXCYTE INC+211.5%
KYMRKYMERA THERAPEUTICS INC+132.7%
+35 more
Trimmed
1
DELLDELL TECHNOLOGIES INC-15.3%

Unlock alerts, watchlists & AI chat

Sign up free to track Odyssean LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Odyssean LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2092853). View Odyssean LLCโ€™s 13F filings on SEC

More 13F analyses

View all